Evidence map›Paper›PMID 31464417›Full record

ArticleACS chemical biology2019

Leveraging Peptide Substrate Libraries to Design Inhibitors of Bacterial Lon Protease.

Brett M Babin, Paulina Kasperkiewicz, Tomasz Janiszewski, Euna Yoo, Marcin Dra G, Matthew Bogyo

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Proteostasis-targeted antibacterial strategies.Journal of microbiology (Seoul, Korea) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Targeting lon protease to inhibit persister cell formation inFrontiers in cellular and infection microbiology · 2024
    Article
  7. Review
  8. Non-Canonical Amino Acids in Analyses of Protease Structure and Function.International journal of molecular sciences · 2023
    Review
  9. mBio · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Peptides, Antibodies, Peptide Antibodies and More.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Brett M Babin
Paulina KasperkiewiczDepartment of Bioorganic Chemistry, Faculty of Chemistry , Wrocław University of Science and Technology , Wrocław , Poland.
Tomasz JaniszewskiDepartment of Bioorganic Chemistry, Faculty of Chemistry , Wrocław University of Science and Technology , Wrocław , Poland.
Euna Yoo
Marcin Dra GDepartment of Bioorganic Chemistry, Faculty of Chemistry , Wrocław University of Science and Technology , Wrocław , Poland.
Stanford University · USWrocław University of Science and Technology · PL

Funding

MOLECULAR BASIS OF HOST-PARASITE INTERACTIONT32AI007328 · NIAID · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 1987 to 2026
$11.9M
Generation of highly selective activity based probes using chemically modified phageR01EB026285 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2018 to 2021
$1.9M
Staphylococcus serine hydrolases as targets for therapeutic and imaging contrast agentsR01EB026332 · NIBIB · STANFORD UNIVERSITY · PI BOGYO, MATTHEW · 2018 to 2021
$1.4M
NIAID NIH HHS T32 AI007328NIBIB NIH HHS R01 EB026285NIBIB NIH HHS R01 EB026332
6 · The paper itself

Abstract

Lon is a widely conserved housekeeping protease found in all domains of life. Bacterial Lon is involved in recovery from various types of stress, including tolerance to fluoroquinolone antibiotics, and is linked to pathogenesis in a number of organisms. However, detailed functional studies of Lon have been limited by the lack of selective, cell-permeant inhibitors. Here, we describe the use of positional scanning libraries of hybrid peptide substrates to profile the primary sequence specificity of bacterial Lon. In addition to identifying optimal natural amino acid binding preferences, we identified several non-natural residues that were leveraged to develop optimal peptide substrates as well as a potent peptidic boronic acid inhibitor of Lon. Treatment of

Indexed as

Peptide LibraryAmino Acid SequenceAnimalsBoronic AcidsCiprofloxacinEnzyme InhibitorsEscherichia coliEscherichia coli ProteinsHumansMiceMutationOligopeptidesProtease LaProteasome Endopeptidase ComplexProtein BindingRAW 264.7 CellsBoronic AcidsCiprofloxacinEnzyme InhibitorsEscherichia coli ProteinsLon protein, E coliOligopeptidesPeptide LibraryProtease LaProteasome Endopeptidase Complex

Identifiers

PMID31464417
PMCPMC6858493
OpenAlexW2970018255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.